−0.024 GBP
−3.12 M GBP
587.00 K GBP
1.28 B
About SOLVONIS THERAPEUTICS PLC ORD GBP0.001
Sector
Industry
CEO
Anthony Tennyson
Website
Headquarters
London
Founded
2017
ISIN
GB00BMD1Z199
FIGI
BBG0147DYM62
Solvonis Therapeutics Plc is a holding company, which engages in the development and production of polymer. It improves existing products and processing methodologies by enhancing performance, simplifying manufacturing, reducing material consumption, widening the choice of feedstocks, and reducing costs. The company was founded by Victor Bolduev in 2017 and is headquartered in London, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SVNS is 0.205 GBX — it has increased by 5.41% in the past 24 hours. Watch SOLVONIS THERAPEUTICS PLC ORD GBP0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange SOLVONIS THERAPEUTICS PLC ORD GBP0.001 stocks are traded under the ticker SVNS.
SVNS stock has risen by 16.77% compared to the previous week, the month change is a 16.77% rise, over the last year SOLVONIS THERAPEUTICS PLC ORD GBP0.001 has showed a 22.75% increase.
SVNS reached its all-time high on Jan 17, 2025 with the price of 0.190 GBX, and its all-time low was 0.150 GBX and was reached on Jan 16, 2025. View more price dynamics on SVNS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SVNS stock is 26.10% volatile and has beta coefficient of −2.73. Track SOLVONIS THERAPEUTICS PLC ORD GBP0.001 stock price on the chart and check out the list of the most volatile stocks — is SOLVONIS THERAPEUTICS PLC ORD GBP0.001 there?
Yes, you can track SOLVONIS THERAPEUTICS PLC ORD GBP0.001 financials in yearly and quarterly reports right on TradingView.
SVNS net income for the last half-year is −626.00 K GBP, while the previous report showed −1.99 M GBP of net income which accounts for 68.61% change. Track more SOLVONIS THERAPEUTICS PLC ORD GBP0.001 financial stats to get the full picture.
No, SVNS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SOLVONIS THERAPEUTICS PLC ORD GBP0.001 EBITDA is −1.64 M GBP, and current EBITDA margin is −346.00%. See more stats in SOLVONIS THERAPEUTICS PLC ORD GBP0.001 financial statements.
Like other stocks, SVNS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SOLVONIS THERAPEUTICS PLC ORD GBP0.001 stock right from TradingView charts — choose your broker and connect to your account.